Correlation Between Medipharm Labs and Integrated Cannabis

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Medipharm Labs and Integrated Cannabis at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Medipharm Labs and Integrated Cannabis into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Medipharm Labs Corp and Integrated Cannabis Solutions, you can compare the effects of market volatilities on Medipharm Labs and Integrated Cannabis and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Medipharm Labs with a short position of Integrated Cannabis. Check out your portfolio center. Please also check ongoing floating volatility patterns of Medipharm Labs and Integrated Cannabis.

Diversification Opportunities for Medipharm Labs and Integrated Cannabis

0.09
  Correlation Coefficient

Significant diversification

The 3 months correlation between Medipharm and Integrated is 0.09. Overlapping area represents the amount of risk that can be diversified away by holding Medipharm Labs Corp and Integrated Cannabis Solutions in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Integrated Cannabis and Medipharm Labs is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Medipharm Labs Corp are associated (or correlated) with Integrated Cannabis. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Integrated Cannabis has no effect on the direction of Medipharm Labs i.e., Medipharm Labs and Integrated Cannabis go up and down completely randomly.

Pair Corralation between Medipharm Labs and Integrated Cannabis

Assuming the 90 days horizon Medipharm Labs is expected to generate 37.39 times less return on investment than Integrated Cannabis. But when comparing it to its historical volatility, Medipharm Labs Corp is 3.66 times less risky than Integrated Cannabis. It trades about 0.01 of its potential returns per unit of risk. Integrated Cannabis Solutions is currently generating about 0.12 of returns per unit of risk over similar time horizon. If you would invest  0.05  in Integrated Cannabis Solutions on August 26, 2024 and sell it today you would earn a total of  0.32  from holding Integrated Cannabis Solutions or generate 640.0% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthInsignificant
Accuracy100.0%
ValuesDaily Returns

Medipharm Labs Corp  vs.  Integrated Cannabis Solutions

 Performance 
       Timeline  
Medipharm Labs Corp 

Risk-Adjusted Performance

1 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Medipharm Labs Corp are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable forward indicators, Medipharm Labs is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
Integrated Cannabis 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Integrated Cannabis Solutions are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. Despite quite fragile basic indicators, Integrated Cannabis disclosed solid returns over the last few months and may actually be approaching a breakup point.

Medipharm Labs and Integrated Cannabis Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Medipharm Labs and Integrated Cannabis

The main advantage of trading using opposite Medipharm Labs and Integrated Cannabis positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Medipharm Labs position performs unexpectedly, Integrated Cannabis can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Integrated Cannabis will offset losses from the drop in Integrated Cannabis' long position.
The idea behind Medipharm Labs Corp and Integrated Cannabis Solutions pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..

Other Complementary Tools

Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets